Clinically Relevant Progestins Regulate Neurogenic and Neuroprotective Responses in Vitro and in Vivo
Open Access
- 13 October 2010
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 151 (12) , 5782-5794
Abstract
Previously, we demonstrated that progesterone (P4) promoted adult rat neural progenitor cell (rNPC) proliferation with concomitant regulation of cell-cycle gene expression via the P4 receptor membrane component/ERK pathway. Here, we report the efficacy of seven clinically relevant progestins alone or in combination with 17β-estradiol (E2) on adult rNPC proliferation and hippocampal cell viability in vitro and in vivo. In vitro analyses indicated that P4, norgestimate, Nestorone, norethynodrel, norethindrone, and levonorgestrel (LNG) significantly increased in rNPC proliferation, whereas norethindrone acetate was without effect, and medroxyprogesterone acetate (MPA) inhibited rNPC proliferation. Proliferative progestins in vitro were also neuroprotective. Acute in vivo exposure to P4 and Nestorone significantly increased proliferating cell nuclear antigen and cell division cycle 2 expression and total number of hippocampal 5-bromo-2-deoxyuridine (BrdU)-positive cells, whereas LNG and MPA were without effect. Mechanistically, neurogenic progestins required activation of MAPK to promote proliferation. P4, Nestorone, and LNG significantly increased ATP synthase subunit α (complex V, subunit α) expression, whereas MPA was without effect. In combination with E2, P4, Nestorone, LNG, and MPA significantly increased BrdU incorporation. However, BrdU incorporation induced by E2 plus LNG or MPA was paralleled by a significant increase in apoptosis. A rise in Bax/Bcl-2 ratio paralleled apoptosis induced by LNG and MPA. With the exception of P4, clinical progestins antagonized E2-induced rise in complex V, subunit α. These preclinical translational findings indicate that the neurogenic response to clinical progestins varies dramatically. Progestin impact on the regenerative capacity of the brain has clinical implications for contraceptive and hormone therapy formulations prescribed for pre- and postmenopausal women.Keywords
This publication has 38 references indexed in Scilit:
- Ultrastructural localization of extranuclear progestin receptors in the rat hippocampal formationJournal of Comparative Neurology, 2008
- EstradiolIn VivoRegulation of Brain Mitochondrial ProteomeThe Journal of Neuroscience, 2007
- Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?Climacteric, 2007
- Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapyGynecologic Oncology, 2005
- The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein ExpressionJournal of Neuroscience, 2005
- Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signalingProceedings of the National Academy of Sciences, 2003
- Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 womenClimacteric, 2002
- Hormonal Replacement TherapyReviews in Endocrine and Metabolic Disorders, 2002
- Progestogens in hormonal replacement therapy: new molecules, risks, and benefitsMenopause, 2002
- Nestorone®: a progestin with a unique pharmacological profileSteroids, 2000